About US BioTek Laboratories
US BioTek Laboratories is a company based in Shoreline (United States) founded in 2008 was acquired by Pike Street Capital in December 2018. US BioTek Laboratories has raised $19.5 million across 2 funding rounds from investors including Capitala Group and Pike Street Capital. US BioTek Laboratories has completed 1 acquisition, including RealTime Laboratories. US BioTek Laboratories offers products and services including Food Sensitivity Testing, Allergy Testing, GI Microbiome Testing, Organic Acids Testing, and Mycotoxin Testing. US BioTek Laboratories operates in a competitive market with competitors including Abingdon Health, Spear Bio, Olink, Virtue Diagnostics and Eclipse Bio, among others.
- Headquarter Shoreline, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Us Biotek Laboratories, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$19.5 M (USD)
in 2 rounds
-
Latest Funding Round
$19.5 M (USD), Series A
Jan 13, 2019
-
Investors
Capitala Group
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Pike Street Capital
(Dec 18, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of US BioTek Laboratories
US BioTek Laboratories offers a comprehensive portfolio of products and services, including Food Sensitivity Testing, Allergy Testing, GI Microbiome Testing, Organic Acids Testing, and Mycotoxin Testing.
Identifies potential food sensitivities through blood analysis.
Detects allergies via specialized blood tests.
Analyzes gut bacteria for health and imbalance insights.
Evaluates metabolic markers for nutritional and environmental factors.
Assesses exposure to toxins from molds and their health impacts.
People of US BioTek Laboratories
Unlock access to complete
Funding Insights of US BioTek Laboratories
US BioTek Laboratories has successfully raised a total of $19.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $19.5 million completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in US BioTek Laboratories
US BioTek Laboratories has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Capitala Group and Pike Street Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global multi-sector investments are managed by the private equity firm.
|
Locked | Locked | Locked | |
|
Pike Street Capital is engaged in middle market growth buyouts.
|
Locked | Locked | Locked |
Investor details for US BioTek Laboratories
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by US BioTek Laboratories
US BioTek Laboratories has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include RealTime Laboratories.
Investment portfolio details for US BioTek Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of mycotoxin testing for detecting different mycotoxins
|
Locked | Locked | 2005 | Locked |
Complete acquisition details for US BioTek Laboratories
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - US BioTek Laboratories
Detailed financials for US BioTek Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Us Biotek Laboratories Comparisons
Peer comparison for US BioTek Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of US BioTek Laboratories
US BioTek Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abingdon Health, Spear Bio, Olink, Virtue Diagnostics and Eclipse Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of immunoassays for diagnostic purposes
|
|
| Locked | Locked | Locked |
Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers
|
|
| Locked | Locked | Locked |
Provider of products and services for human protein biomarker research and development
|
|
| Locked | Locked | Locked |
An in vitro assay platform is provided for diagnostic solutions.
|
|
| Locked | Locked | Locked |
Cell-free immunoassays are developed to identify RNA binding protein targets.
|
|
| Locked | Locked | Locked |
Correlia Biosystems is focused on protein quantification technology.
|
Detailed competitors of US BioTek Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Us Biotek Laboratories
Complete news archive for US BioTek Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about US BioTek Laboratories
US BioTek Laboratories was founded in 2008 and raised its 1st funding round 11 years after it was founded.
US BioTek Laboratories is headquartered in Shoreline, United States. It is registered at Shoreline, Washington, United States.
US BioTek Laboratories is a funded company, having raised a total of $19.5M across 2 funding rounds to date.
US BioTek Laboratories was established in 2008 in Shoreline, United States, within the medical laboratory sector. Enzyme-linked immunosorbent assay methods are utilized for IgA, IgG, and Candida antibody testing. Chemiluminescence techniques are applied for IgE and Celiac antibody analysis related to common foods, inhalants, and molds. Operations occur in Clinical Laboratory Improvement Amendments-accredited facilities focused on diagnostic services.
US BioTek Laboratories's top competitors include Abingdon Health, Eclipse Bio and Spear Bio.
US BioTek Laboratories offers Food Sensitivity Testing, Allergy Testing, GI Microbiome Testing, Organic Acids Testing, and Mycotoxin Testing.
US BioTek Laboratories has made 1 acquisition, including RealTime Laboratories.
US BioTek Laboratories has 2 investors. Key investors include Capitala Group, and Pike Street Capital.